MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis. - Wikidata - wikimedia - TriplyDB

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

http://www.wikidata.org/entity/Q37872630

about

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis Analyzing association of the XRCC3 gene polymorphism with ovarian cancer risk.Association between murine double minute 2 T309G polymorphism and risk of liver cancer.The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers.Negative selection maintains transcription factor binding motifs in human cancer.Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis Genetic variants and mutations of PPM1D control the response to DNA damage.MDM2 rs2279744 polymorphism and endometrial cancer: a meta-analysis.Polymorphisms in the MDM2 gene and risk of malignant bone tumors: a meta-analysis.Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer risk.MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs.Quantitative assessment of the association between HDMX polymorphism and sarcoma.MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers.Association of rs2279744 and rs117039649 promoter polymorphism with the risk of gynecological cancer: A meta-analysis of case-control studies.

P2860

Q33643505-761E9E32-3399-499C-8950-F96A5F032797 Q33810401-DA60A9E6-617C-44DB-9921-B0C0F6F0CB83 Q34433411-75A84CCF-CF43-46E4-831E-AD66E68F8D1D Q34575963-9618F430-DFE4-4D80-B944-933050FC6F9A Q35751762-BCD4C258-08CC-4BA4-A5DC-A88E903CF1EE Q36064184-F88D2A06-3850-4CE7-8F21-7B7ABE69B8E2 Q36109482-09952F4E-E4E2-452C-83F2-E1FEF87B3CA5 Q37059477-19058C8B-31CD-4FE9-AFFE-C54F08D8C94B Q37205283-6C4981EF-5634-42CA-8648-909C73955614 Q37396919-EB1A6881-911E-44F8-BB90-C17A1AB1C9A5 Q43679610-8447185F-E901-4A1C-A9B4-1D847F01DC29 Q44820188-4B191A88-6A9F-458C-8856-0C1A67AC9071 Q45231714-BFDA573B-510A-4529-BF7A-3165F1250337 Q47799677-48134FEE-D63E-4FC7-BDAB-28F114D10D40 Q51006023-D4560898-DDC2-41C3-8746-523D994C4D68 Q53147977-6950A477-9EAD-46CB-BAA4-55D01D6F0B6E Q54439530-EA8A948A-5E96-45C1-B0AC-7B0C1ACA07D9 Q54959231-568F4239-D6AD-4D04-A8DE-B53A693268DF

P2860

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

http://www.wikidata.org/entity/Q37872630

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

@en

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

@nl

type

label

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

@en

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

@nl

prefLabel

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

@en

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

@nl

P1433

Q37872630-6BCAD27C-6CD3-4134-A281-581FC6A52E4D

P1476

Q37872630-D3405285-30FE-42B7-BB7D-65595230B148

P2093

Q37872630-24F3BF37-7F74-44A0-9227-6D622D0CA74C

Q37872630-3638AF7B-AE1E-428F-9CEA-E184DC697499

Q37872630-3AC67C4A-09FA-4DA1-9890-DFD59F4DAE00

Q37872630-BB34F0C1-D87C-4924-B958-BBECE12777D6

Q37872630-CF49D127-D93F-43FA-8A34-840A30DD56E1

Q37872630-D13D4BDD-6285-497F-9157-AD1B2F1BC4AF

P2860

Q37872630-05619320-EC0D-446C-A4EB-33BB391BEA99

Q37872630-08CC115B-B268-4A39-94B7-88E8101A0BD1

Q37872630-23B85277-98BC-4979-A906-E9F4C8F56EA6

Q37872630-240657FB-372C-4300-84EE-EBF44D9901DA

Q37872630-2DF67B4C-F030-4FCF-A79A-EE5A3DEF8ABB

Q37872630-316C91C3-63AF-4725-B037-94A79ED15460

Q37872630-3D2A2615-8818-45ED-80E7-4FCD58E0017E

Q37872630-406867FB-DBA8-45ED-86A4-F565140F6ACF

Q37872630-444A2B88-68B9-4AE9-B775-6F30E5DE4395

Q37872630-461CF9BB-B47E-49AE-B517-CA083C8E03E2

P2888

Q37872630-C8CC7F56-BCC5-4D69-8B78-77529A181861

P304

Q37872630-C4D8F982-D4DC-4A2A-B2DF-47820C9EC565

P31

Q37872630-886f1852-6963-4226-a764-3c1a4ef12c02

Q37872630-F32FD571-2A1C-4F60-BF56-6CA311CFC242

P356

Q37872630-A7C8A1E0-49C1-488E-A30E-B896CF1D3727

P433

Q37872630-C2AF0135-4766-44E5-827A-B0A414609BD0

P478

Q37872630-64C53A93-4D50-4B2F-93F0-B9662BED99DC

P577

Q37872630-AE3C2E0D-5754-46B5-93F7-3172B259DE7B

P698

Q37872630-34FEECF7-6D4C-403D-AECE-36547EC8DA2A

P921

Q37872630-EA64BD27-80FE-4D9C-9083-0757C39C376F

P356

S13577-011-0013-4

P1433

P1476

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

@en

P2093

Beihua Kong

http://www.w3.org/2001/XMLSchema#string

Hongjin Zhao

http://www.w3.org/2001/XMLSchema#string

Li Sun

http://www.w3.org/2001/XMLSchema#string

Linjuan Huang

http://www.w3.org/2001/XMLSchema#string

Qifeng Yang

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

The Sequence of the Human Genome

Mdm2 promotes the rapid degradation of p53

Bias in meta-analysis detected by a simple, graphical test

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.

Measuring inconsistency in meta-analyses

Regulation of p53 stability by Mdm2

Meta-analysis in clinical trials

Amplification of a gene encoding a p53-associated protein in human sarcomas

The p53 pathway: positive and negative feedback loops

Detection of functional single-nucleotide polymorphisms that affect apoptosis

P2888

s13577-011-0013-4

P304

57-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13577-011-0013-4

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21547352

http://www.w3.org/2001/XMLSchema#string

P921